GET THE APP

Quantitative analysis of serum dipeptidyl peptidase IV enzyme in oral squamous cell carcinoma | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Quantitative analysis of serum dipeptidyl peptidase IV enzyme in oral squamous cell carcinoma

Author(s): Prashant V. Kandekar, Avinash Tamgadge and Suresh Meshram

Dipeptidyl Peptidase IV (DPP IV) is an enzyme which splits N-terminal X-proline from peptides. The objective of this study was to present a reliable test to quantitatively estimate the serum Dipeptidyl Peptidase IV enzyme in oral cancer patients and to ascertain if Dipeptidyl Peptidase IV can be used as a tumor marker in the early diagnosis of cancer. The study was performed on 31 patients with different stages of oral squamous cell carcinoma as a study group and 10 control healthy group. The mean DPP IV activity in study group was significantly lower than control group. Among the study group, well differentiated squamous cell carcinoma had the highest mean serum DPP IV activity than moderately and poorly differentiated squamous cell carcinoma. We hence conclude that DPP IV activity in serum can be used as a biochemical marker in the diagnosis of oral squamous cell carcinoma.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 15261

Der Pharma Chemica received 15261 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry